Duloxetine paten?

What “duloxetine patent” usually means (and which product)

“Duloxetine” is the active ingredient in medicines such as Cymbalta (brand duloxetine). Patent questions can refer to the original drug patent, later “second-generation” patents (new formulations or dosing), or patent exclusivity protections that keep generics from launching in certain countries. The key answer depends on the country and which duloxetine product (e.g., immediate-release vs delayed-release) you mean.

When does duloxetine (Cymbalta) patent expire?

I don’t have the specific patent numbers, filing jurisdictions, or expiry dates in the provided information, so I can’t give a reliable expiration timeline. Duloxetine patent timelines also vary by:
- Country (US vs EU vs UK vs India, etc.)
- Patent type (composition of matter vs formulation/device vs method of use)
- Patent term adjustments and extensions
- Additional exclusivities (where applicable)

If you share the country (or a specific patent/application number), I can narrow to the correct expiry date(s).

Can generic duloxetine be sold before the original patent expires?

Typically, generic manufacturers may be able to pursue approval applications ahead of expiry, but they generally cannot market the generic until patent and exclusivity barriers clear (unless a specific licensing or carve-out applies). The exact timing depends on which patents are listed as blocking in that jurisdiction.

What patents commonly cover duloxetine besides the original drug?

Duloxetine patent families often include secondary protections such as:
- Specific drug formulations (e.g., release characteristics)
- Manufacturing processes
- Methods of treatment (certain indications or dosing regimens)
- Delivery technologies

Because these can expire at different times, the “patent expiry” date that matters for generics is usually the latest relevant blocking right in that country for the exact product being copied.

How to look up the exact duloxetine patent for your country

To get an accurate expiry date, you usually need:
- The product name and strength (e.g., Cymbalta 30 mg/60 mg; capsule type)
- The country/region
- The specific patent(s) listed in national registers for that medicine

Common places to check are national patent databases and drug-specific regulator listings, but I need the country or patent identifier to point you to the right documents.

Tell me what you need, and I’ll pin down the date(s)

Reply with one of the following and I’ll take it from there:
- The country (e.g., US, UK, EU, Canada, India)
- The brand/product you mean (e.g., Cymbalta)
- Any patent number or link you have
- Whether you care about original duloxetine or a specific formulation (immediate vs delayed release)

Sources

None provided in the conversation.